These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35177062)

  • 1. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations.
    Head JR; Andrejko KL; Remais JV
    medRxiv; 2021 Aug; ():. PubMed ID: 34462757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.
    Giardina J; Bilinski A; Fitzpatrick MC; Kendall EA; Linas BP; Salomon J; Ciaranello AL
    JAMA Netw Open; 2022 Feb; 5(2):e2147827. PubMed ID: 35157056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
    Aruffo E; Yuan P; Tan Y; Gatov E; Moyles I; Bélair J; Watmough J; Collier S; Arino J; Zhu H
    BMC Public Health; 2022 Jul; 22(1):1349. PubMed ID: 35841012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
    JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.
    Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W
    Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era.
    Shah SA; Robertson C; Rudan I; Murray JL; McCowan C; Grange Z; Buelo A; Sullivan C; Simpson CR; Ritchie LD; Sheikh A
    J Glob Health; 2022; 12():05008. PubMed ID: 35356660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
    Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
    JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of re-opening the international border on COVID-19 hospitalisations in Australia: a modelling study.
    Hanly MJ; Churches T; Fitzgerald O; Post JJ; MacIntyre CR; Jorm L
    Med J Aust; 2022 Jan; 216(1):39-42. PubMed ID: 34633100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies.
    Ryckman T; Chin ET; Prince L; Leidner D; Long E; Studdert DM; Salomon JA; Alarid-Escudero F; Andrews JR; Goldhaber-Fiebert JD
    Lancet Public Health; 2021 Oct; 6(10):e760-e770. PubMed ID: 34364404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.